Amgen Inc (NASDAQ: AMGN)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $281.22
-
Support levelN/A
-
Resistance level$292.34
-
Beta0.4
-
RSI (14-day)46.0
- AMGN is one of this month's worst performers with a return of -9.2 percent, underperforming 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- AMGN is below its 200-day moving average - additional caution warranted in long positions.
- Price broke below prior support level - a short-term bearish signal.
52-week low | 52-week high | Price as % of range |
---|---|---|
$258.59 | $337.38 | 31.5% |
200 day | 50 day | 20 day | 10 day |
---|---|---|---|
$303.72 | $301.25 | $284.51 | $281.82 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week7.1%
-
In the next month14.5%
-
In the next year52.3%
Period | Value |
---|---|
Historical (5 year) | 25.7% |
Last month | 22.2% |
Current estimate | 26.3% |
Next month forecast | 25.6% |